Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Assets Average (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Assets Average for 6 consecutive years, with $98.4 million as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Assets Average fell 7.07% year-over-year to $98.4 million, compared with a TTM value of $98.4 million through Sep 2019, down 7.07%, and an annual FY2018 reading of $113.6 million, down 4.16% over the prior year.
  • Assets Average was $98.4 million for Q3 2019 at Larimar Therapeutics, down from $107.0 million in the prior quarter.
  • Across five years, Assets Average topped out at $229.7 million in Q2 2015 and bottomed at $86.2 million in Q2 2018.
  • Average Assets Average over 5 years is $138.4 million, with a median of $125.5 million recorded in 2017.
  • The sharpest move saw Assets Average skyrocketed 61.31% in 2015, then plummeted 31.06% in 2017.
  • Year by year, Assets Average stood at $198.3 million in 2015, then tumbled by 30.82% to $137.2 million in 2016, then decreased by 26.45% to $100.9 million in 2017, then rose by 25.74% to $126.9 million in 2018, then fell by 22.44% to $98.4 million in 2019.
  • Business Quant data shows Assets Average for LRMR at $98.4 million in Q3 2019, $107.0 million in Q2 2019, and $116.0 million in Q1 2019.